What it's actually good for
Tongkat ali (Eurycoma longifolia) is a root from a Southeast Asian tree, used traditionally as a tonic and aphrodisiac and now sold as a "natural testosterone booster." That marketing gets ahead of the evidence, but the evidence isn't nothing either — which is why this sits at a C rather than an F. A handful of small, mostly manufacturer-funded RCTs show measurable hormonal effects, and the direction is consistent across studies even though the size and populations vary.
What the research says
Testosterone (Grade C — real signal, thin base). A 2022 systematic review and meta-analysis (Leisegang et al., Medicina) pooled 5 RCTs and 232 men and found a statistically significant increase in total testosterone (SMD 1.352). But the authors flagged two problems worth taking seriously: heterogeneity across the pooled trials was very high (I²=87%), and a Begg's test suggested publication bias — meaning smaller or null trials may be missing from the literature. The effect was also driven almost entirely by men with low baseline testosterone (hypogonadal), not healthy volunteers, whose results didn't reach significance. Read plainly: tongkat ali may nudge testosterone up in men who are already low, but "boosts T in healthy men" isn't what this dataset actually shows.
Stress and cortisol (Grade C). The most-cited trial here is Talbott et al. 2013 (J Int Soc Sports Nutr): 63 moderately stressed adults took 200 mg/day for 4 weeks and saw a 16% drop in salivary cortisol and a 37% rise in testosterone versus placebo, plus improved tension, anger, and confusion scores — though no change in depression, vigor, or fatigue. It's a real randomized trial with plausible results, but it's one study, four weeks long, and funded by the extract's manufacturer. That combination — genuine signal, thin independent replication — is the pattern across this ingredient's whole literature.
Athletic performance and body composition. Claims here rest on the same small trial pool and haven't been separately confirmed by an independent meta-analysis. Treat any performance claim as an extension of the testosterone data, not a separately proven benefit.
How much, and which form
Studies mostly use 200–400 mg/day of a standardized water-extracted root, commonly standardized to eurycomanone content (the Physta extract used in the Talbott trial is one example). Extraction ratio (e.g., 100:1, 200:1) is a reasonable quality signal since raw root powder is far weaker. Cycling on and off is commonly recommended in marketing but isn't backed by trial data — every RCT here just dosed continuously.
Safety & interactions
Trials running up to 12 weeks report good tolerability, with occasional restlessness or insomnia. Long-term data essentially doesn't exist — no RCT has run past three months. A 2024 case report (Kaliounji et al., Cureus) documented acute liver injury in a bodybuilder that resolved after he stopped a tongkat ali supplement — the first such case in the literature. A single case report doesn't establish causality, but it's a reason to take any new jaundice or dark urine seriously and stop use. Given the hormonal mechanism, anyone on hormone therapy or blood pressure medication should talk to a clinician before starting, and supplement quality matters more than usual here — sourcing verified, standardized extract from a tested brand.
How we picked the brand
A tongkat ali product earns a spot when it uses a standardized water-extracted root — ideally with a stated extraction ratio (e.g. 200:1) and a verified eurycomanone percentage — rather than raw root powder, sits in the 200–400 mg/day range the trials used, and passes independent third-party testing for identity and potency. Unstandardized "tongkat" with no eurycomanone spec has essentially no trial data behind it at supplement doses, and because this is an ingredient where a single liver-injury case report exists, verified sourcing matters more than usual.